Vol 8, Supplement 3 (July 2019): Translational Andrology and Urology

Editorial Commentary

Long term results of the NRG/RTOG 9413: a key study but one of the most confusing study in prostate cancer radiotherapy!
Pascal Pommier
Association between perioperative morbidity and mortality after radical cystectomy: an opportunity to understand the complication snowball effect
Vignesh T. Packiam, Joseph J. Pariser
Can the interplay between androgen signaling and PSMA expression be leveraged for theranostic applications?
Jaspreet S. Batra, Kenneth J. Pienta, Martin G. Pomper, Michael A. Gorin, Steven P. Rowe
Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/RTOG 0526)
Randall J. Brenneman, Edward Soffen, Hiram A. Gay, Peter F. Orio III, John P. Christodouleas, John C. Baumann, Brian C. Baumann
Experience of surgeon, hospital, and comprehensive cancer team critical to the outcomes of radical cystectomy and urinary diversion
Ram Anil Pathak, Ashok Kumar Hemal
Should every patient with muscle-invasive bladder cancer receive neoadjuvant chemotherapy?
Moritz Maas, Arnulf Stenzl
The clinical and economic burden of perioperative complications of radical cystectomy
Christine W. Liaw, Jared S. Winoker, Peter Wiklund, John Sfakianos, Matthew D. Galsky, Reza Mehrazin
Adjuvant chemotherapy in bladder cancer patients with histological variants: time to change the approach?
Luca Afferi, Stefania Zamboni, Philipp Baumeister, Livio Mordasini, Agostino Mattei, Marco Moschini
Should we spare neoadjuvant chemotherapy in low-risk muscle-invasive bladder cancer patients scheduled for radical cystectomy?
Günter Niegisch
Changes in testosterone prescribing patterns after FDA warning
Soum D. Lokeshwar, Joshua Bitran, Ranjith Ramasamy
Perioperative mortality following radical cystectomy: the slippery slope of complications
Marc H. Nelson, Marcus L. Quek
Prognostic impact of tumor infiltrating lymphocytes in bladder urothelial carcinoma
Hyung Suk Kim, Ja Hyeon Ku
Molecular subtypes and response to immunotherapy in bladder cancer patients
Tilman Todenhöfer, Roland Seiler
Editorial: assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer, a prospective single arm clinical study: California shows the way!
Peter Choyke
Bladder organoids: a step towards personalised cancer therapy?
Sreemoti Banerjee, Jennifer Southgate
The docetaxel debate: impact of chemotherapy in high-risk non-metastatic prostate cancer
Mark D. Hurwitz
Editorial: early PSA-testing after radical prostatectomy—the truth behind the scenes
Julian Hanske, Florian Roghmann, Joachim Noldus, Marko Brock
Establishing and characterization of human and murine bladder cancer organoids
Neveen Said
Studying the impact of comorbidity on post radical cystectomy survival: have we come a full circle?
Subodh K. Regmi, Badrinath R. Konety
The diagnosis of bladder cancer: are we missing a teachable moment for smoking cessation?
Roman Sosnowski, Hubert Kamecki, Marc A. Bjurlin, Krzysztof Przewoźniak
Looking into the clinical application of CD47-targeted near-infrared photoimmunotherapy for human bladder cancer treatment
Jayoung Kim
Molecular subtyping, tumor infiltration, and trimodal therapy for muscle-invasive bladder cancer: more questions than answers
Ronald Kool, José João Mansure, Wassim Kassouf
How to guide the selection of patients for trimodality therapy: the case for tumor immune and stromal signature
Luca Boeri, R. Jeffrey Karnes, Emanuele Montanari
Significant lack of urine-based biomarkers to replace cystoscopy for the surveillance of non-muscle invasive bladder cancer
Makito Miyake, Takuya Owari, Shunta Hori, Kiyohide Fujimoto
Prognosis in high-grade T1 bladder cancer: host immune response and tumour infiltrating lymphocytes
Su-Min Lee
The risk of oversimplification in risk-stratification of neoadjuvant chemotherapy-responses in muscle invasive bladder cancer
Amir Sherif
Radium-223 plus abiraterone in metastatic castration-resistant prostate cancer: a cautionary tale
Ramy Sedhom, Emmanuel S. Antonarakis